Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Bipolar disorder and substance abuse.

Brown ES.

Psychiatr Clin North Am. 2005 Jun;28(2):415-25. Review.

PMID:
15826740
2.

The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.

Lee JH, Dunner DL.

Depress Anxiety. 2008;25(2):91-7.

PMID:
17311265
3.

Impact of substance abuse on the course and treatment of bipolar disorder.

Salloum IM, Thase ME.

Bipolar Disord. 2000 Sep;2(3 Pt 2):269-80. Review.

PMID:
11249805
4.

The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity.

Bizzarri JV, Sbrana A, Rucci P, Ravani L, Massei GJ, Gonnelli C, Spagnolli S, Doria MR, Raimondi F, Endicott J, Dell'Osso L, Cassano GB.

Bipolar Disord. 2007 May;9(3):213-20.

PMID:
17430295
5.

Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.

Mazza M, Mandelli L, Di Nicola M, Harnic D, Catalano V, Tedeschi D, Martinotti G, Colombo R, Bria P, Serretti A, Janiri L.

J Affect Disord. 2009 May;115(1-2):27-35. doi: 10.1016/j.jad.2008.08.019. Epub 2008 Oct 8.

PMID:
18845344
6.

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.

Beaulieu S, Saury S, Sareen J, Tremblay J, Schütz CG, McIntyre RS, Schaffer A; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force..

Ann Clin Psychiatry. 2012 Feb;24(1):38-55. Review.

PMID:
22303521
7.

Bipolar disorders and quality of life: the impact of attention deficit/hyperactivity disorder and substance abuse in euthymic patients.

Sentissi O, Navarro JC, De Oliveira H, Gourion D, Bourdel MC, Baylé FJ, Olié JP, Poirier MF.

Psychiatry Res. 2008 Oct 30;161(1):36-42. doi: 10.1016/j.psychres.2007.06.016. Epub 2008 Sep 10.

PMID:
18786727
8.

Management of comorbid bipolar disorder and substance abuse.

Vornik LA, Brown ES.

J Clin Psychiatry. 2006;67 Suppl 7:24-30. Review.

9.

Toward a unitary perspective on the bipolar spectrum and substance abuse: opiate addiction as a paradigm.

Maremmani I, Perugi G, Pacini M, Akiskal HS.

J Affect Disord. 2006 Jul;93(1-3):1-12. Epub 2006 May 3. Review.

PMID:
16675028
10.

[Comorbidity and bipolar disorders].

Kahn JP.

Encephale. 2006 Sep;32 Pt 2:S511-4. French. No abstract available.

PMID:
17099565
11.

Update on the treatment and management of schizophrenia and bipolar disorder.

Buckley PF.

CNS Spectr. 2008 Feb;13(2 Suppl 1):1-10; quiz 11-2. Review.

PMID:
18227747
12.

Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.

Horsfall J, Cleary M, Hunt GE, Walter G.

Harv Rev Psychiatry. 2009;17(1):24-34. doi: 10.1080/10673220902724599. Review.

PMID:
19205964
13.

Bipolar spectrum and drug addiction.

Altamura AC.

J Affect Disord. 2007 Apr;99(1-3):285. Epub 2006 Oct 5. No abstract available.

PMID:
17027087
14.

Association of bipolar and substance use disorders in parents of adolescents with bipolar disorder.

Wilens TE, Biederman J, Adamson J, Monuteaux M, Henin A, Sgambati S, Santry A, Faraone SV.

Biol Psychiatry. 2007 Jul 15;62(2):129-34. Epub 2007 May 3.

PMID:
17481590
15.

Risk for substance use disorders in youths with child- and adolescent-onset bipolar disorder.

Wilens TE, Biederman J, Millstein RB, Wozniak J, Hahesy AL, Spencer TJ.

J Am Acad Child Adolesc Psychiatry. 1999 Jun;38(6):680-5.

PMID:
10361785
16.

Major depression and comorbid substance use disorders.

Davis L, Uezato A, Newell JM, Frazier E.

Curr Opin Psychiatry. 2008 Jan;21(1):14-8. doi: 10.1097/YCO.0b013e3282f32408. Review.

PMID:
18281835
17.

Comorbidity in bipolar disorder: a framework for rational treatment selection.

McIntyre RS, Konarski JZ, Yatham LN.

Hum Psychopharmacol. 2004 Aug;19(6):369-86. Review.

PMID:
15303241
18.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
19.

Poor adherence to treatment associated with a high recurrence in a bipolar disorder outpatient sample.

Gutiérrez-Rojas L, Jurado D, Martínez-Ortega JM, Gurpegui M.

J Affect Disord. 2010 Dec;127(1-3):77-83. doi: 10.1016/j.jad.2010.05.021. Epub 2010 Jun 25.

PMID:
20576292
20.

Naltrexone in patients with bipolar disorder and alcohol dependence.

Brown ES, Beard L, Dobbs L, Rush AJ.

Depress Anxiety. 2006;23(8):492-5.

PMID:
16841344

Supplemental Content

Support Center